If they can't afford it they can't afford it right now. Getting a big PR firm at this point would be negligent in my opinion when the money should be spent on developing products. I want the word out just as bad. AMBS is not at the stage just quite yet where the word needs to be out with the consumer. The right people are in the know right now.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links